Newsletters
-
PD for Thu 17 Oct 2024
Thursday | Oct 17 2024TWC slams Sigma/CW merger, TGA denies Alzheimer's treatment registration, mRNA vaccine study, new COPD standard, Wizard's new pharmacy and much more.
-
PD for Wed 16 Oct 2024
Wednesday | Oct 16 2024Amcal enters new era, more support for NSW pharmacists, DDS on "solid ground", combined jab being trialled, and much more.
-
PD for Tue 15 Oct 2024
Tuesday | Oct 15 2024Prac payments campaign, Spontan's study success, seizure safety highlighted this month, Assistants Day, and more.
-
PD for Mon 14 Oct 2024
Monday | Oct 14 2024Thousands in rural areas screened for CVD risk, GP body slams Qld pilots, StrongRoom AI migrates to a new system, dementia tops lead cause list, and more.
-
PD for Fri 11 Oct 2024
Friday | Oct 11 2024Queensland Labor backs scope expansion, Healthy Bones Australia report launched, John Coppock award winner, TGA's new MoU, and more.
-
PD for Thu 10 Oct 2024
Thursday | Oct 10 2024Prime Minister's top prize for innovation awarded, NSW S3 vapes audit tool, urgency for sarcoma funding, APP2025 theme, Beauty and Wellness, and more.
-
PD for Wed 09 Oct 2024
Wednesday | Oct 9 2024TWC and Sanofi tie up for RUM initiatives, Wesfarmers health index report launched, GSK costs benefits of immunisation, Naloxone awareness, and more.
-
PD for Tue 08 Oct 2024
Tuesday | Oct 8 2024Fred IT's MedView Flow innovation, Pharmacy Council of NSW elections, new dementia clinical trial, Vic Health expands vaccine scope, heart drug PBS listing, and more.
-
PD for Fri 04 Oct 2024
Friday | Oct 4 2024Sigma's undertaking boosts market confidence, oral medication for T2D in children approved, mpox vaccinations reminder, Haleon fellowship, and more.
-
PD for Thu 03 Oct 2024
Thursday | Oct 3 2024Priceline major rebrand announced, Eylea for eye disease gets PBS listing, new cervical screening initiative from Priceline, Beauty & Wellness, and more.
